Enzon Pharmaceuticals, Inc. (ENZN)

Market Cap	4.45M -65.5%
Revenue (ttm)	n/a
Net Income	-5.53M
EPS	-0.07
Shares Out	74.21M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	93,800
Average Volume	57,299
Open	0.0600
Previous Close	0.0700
Day's Range	0.0600 - 0.0600
52-Week Range	0.0150 - 0.1299
Beta	0.08
RSI	49.96
Earnings Date	Feb 20, 2026

About Enzon Pharmaceuticals

Enzon Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the sale of its drug product, PegIntron. The company was formerly known as Enzon, Inc and changed its name to Enzon Pharmaceuticals, Inc. in December 2002. Enzon Pharmaceuticals, Inc. was incorporated in 1981 and is headquartered in Cranford, New Jersey.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1981
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: ENZN